JTL 0.00% 0.5¢ jayex technology limited

Jayex to sell its on-premises Acute (hospital) queue management...

  1. 143 Posts.
    lightbulb Created with Sketch. 28
    Jayex to sell its on-premises Acute (hospital) queue management business for £1.3M (3.1x
    recurring earnings) to Canadian based medical technology company Vitalhub Inc with
    completion expected end of April 2021

    • Vitalhub to purchase all existing hospital contractsin the UK and Australia from Jayex, including
    an Enlighten license to operate the services
    • Transaction value of £1.3M (~$2.4M AUD) in cash and Vitalhub shares + additional earn out
    capacity of up to £1.0M (~$1.8M AUD)
    • Jayex retains all IP and ownership of the Enlighten technology stack
    • Divestment enables Jayex to focus on core and higher-margin NHS GP (Primary Care) and
    Community markets and increase services offered through its SaaS based Connect platform
    Funds released for the development of NZ based cannabis subsidiary

    Now were funded for development of the Medical Marijuana... No cash raise needed this is sounding better by the minute
 
watchlist Created with Sketch. Add JTL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.